TY  - GEN
UR  - https://www.iej.org.za/localisation-of-medical-manufacturing-in-africa/
EP  - 86
N1  - This version is the version of record. For information on re-use, please refer to the publisher?s terms and conditions.
Y1  - 2022/11/04/
A1  - Mugwagwa, Julius
A1  - Banda, Geoffrey
A1  - Mkwashi, Andrew
A1  - Mackintosh, Maureen
AV  - restricted
KW  - Covid-19
KW  -  medical manufacturing
KW  -  Africa
KW  -  pharmaceutical industry
SP  - 1
N2  - The Covid-19 pandemic has once again revealed that it is untenable that, in the majority of African countries, more than 70% of health technology requirements are imported. This moment provides an opportunity for African countries to localise medical manufacturing capacity. The localisation challenge is not only technical but encompasses local and global power dynamics spanning the political, socio-technical and economic aspects. These challenges include catching-up countries having to navigate entrenched, hegemonic, global pharmaceutical value chains, especially in innovator products, which elicit strong backlashes from incumbent companies and their governments. This report emanates from a study commissioned by the Institute for Economic Justice (IEJ), a South African-based think tank. It was carried out between August 2021 and September 2022. With the IEJ, the researchers sought to answer the following main research question: How best can African countries harness and deploy lessons from the Covid-19 pandemic and from other relevant local manufacturing experience, to develop and enhance sustainable capabilities for local manufacturing of medical health products?
ID  - discovery10160615
PB  - Institute for Economic Justice
TI  - Localisation of medical manufacturing in Africa
CY  - Johannesburg, South Africa
ER  -